Starget Pharma

About:

Starget Pharma develops a novel somatostatin-based targeted therapy platform.

Website: http://www.stargetpharma.com

Top Investors: Cancer Focus Fund

Description:

Starget Pharma develops a new generation of targeted radiopharmaceutical technologies for the treatment of solid tumors. Starget Pharma has a pipeline of novel targeted radiopharmaceutical molecules that act as a vector for selectively transferring radioisotopes to cancer tumor tissues.

Total Funding Amount:

$15.1M

Headquarters Location:

Ramat Hasharon, Tel Aviv, Israel

Founded Date:

2019-01-01

Founders:

Ronen Kalmanson, Sigal Kalmanson Cusnir

Number of Employees:

1-10

Last Funding Date:

2024-10-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai